Gary Titus, Director at ImmunoCellular Therapeutics, holds 28.00K shares in ImmunoCellular Therapeutics (Ticker: IMUC), holds 37.09K shares in Sciclone Pharmaceuticals (Ticker: SCLN), holds 2.63K shares in Oruka Therapeutics (Ticker: ORKA).
What is the percentage of profitable transactions made by Gary Titus?
The percentage of profitable transactions made by Gary Titus is 83%.
What is the average return per transaction made by Gary Titus?
The average return per transaction made by Gary Titus is 35.60%.
What stocks does Gary Titus hold?
Gary Titus holds: IMUC, SCLN, ORKA stocks.
What was Gary Titus’s latest transaction?
Gary Titus latest transaction was an Uninformative Buy of ―.
What was Gary Titus's most profitable transaction?
Gary Titus’s most profitable transaction was an Informative Buy of SCLN stock on May 26, 2009. The return on the trade was 69.50%.
What is Gary Titus's role in ImmunoCellular Therapeutics?
Gary Titus's role in ImmunoCellular Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.